Colgate-Palmolive Company $CL Shares Acquired by Procyon Advisors LLC

Procyon Advisors LLC lifted its position in Colgate-Palmolive Company (NYSE:CL) by 135.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 40,444 shares of the company’s stock after purchasing an additional 23,260 shares during the quarter. Procyon Advisors LLC’s holdings in Colgate-Palmolive were worth $3,196,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Henrickson Nauta Wealth Advisors Inc. purchased a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $237,000. Everpar Advisors LLC purchased a new position in Colgate-Palmolive during the 4th quarter worth approximately $290,000. Sagespring Wealth Partners LLC lifted its stake in Colgate-Palmolive by 20.5% during the 4th quarter. Sagespring Wealth Partners LLC now owns 10,423 shares of the company’s stock valued at $824,000 after acquiring an additional 1,775 shares during the period. Everhart Financial Group Inc. purchased a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $208,000. Finally, Central Pacific Bank Trust Division boosted its holdings in shares of Colgate-Palmolive by 13.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 3,558 shares of the company’s stock valued at $281,000 after acquiring an additional 422 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In other news, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This represents a 54.33% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Sally Massey sold 15,851 shares of the stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider owned 13,751 shares in the company, valued at $1,306,757.53. This trade represents a 53.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 184,683 shares of company stock worth $17,486,693. Company insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on CL shares. Wells Fargo & Company raised their target price on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a report on Sunday, February 1st. Wall Street Zen raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Saturday. Bank of America lifted their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus price target of $94.75.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $85.14 on Friday. The company has a market capitalization of $68.62 billion, a PE ratio of 32.49, a price-to-earnings-growth ratio of 3.81 and a beta of 0.28. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The company’s fifty day moving average price is $91.01 and its 200 day moving average price is $83.36. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter in the prior year, the firm posted $0.91 earnings per share. The company’s revenue was up 5.8% compared to the same quarter last year. On average, research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s payout ratio is currently 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.